RecruitingNot ApplicableNCT07425015

Ambulatory Long Length URodynamics Evaluation

Sponsor

Bright Uro

Enrollment

101 participants

Start Date

Feb 17, 2026

Study Type

INTERVENTIONAL

Conditions

Benign Prostatic Hyperplasia Urodynamics Urinary Bladder, Overactive Urinary Incontinence (UI)Urology Home Monitoring Lower Urinary Tract Dysfunction

Summary

A prospective, open-label, single arm interventional trial evaluating the safety and performance of the in-clinic and extended monitoring of the lower urinary tract using the Glean Urodynamics System.

Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Glean Urodynamics System for people with benign prostatic hyperplasia, home monitoring, and other related conditions. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.